FDA clears Radionics' immobilisation device:
This article was originally published in Clinica
Radionics has received US 510(k) marketing clearance for its device for immobilising and localising patients undergoing stereotactic radiation therapy treatments. The Body System device, which is used with Radionics' XPlan and IMRT (Intensity Modulated Radiation Therapy) treatment planning system, makes it possible to reproduce the set-up of the patient receiving fractionated treatments and align the radiation beam precisely to the tumour volume. This allows the tumour to be treated effectively while sparing the surrounding tissue, says the company, a division of Tyco Healthcare.